Not all participating programs have posted their residency listings on this portal. To view a full list of participating programs and their physical location in the Residency Showcase, please visit the floor plan.
To print or get a different view of these listings, you can view them in the sortable Google Sheet. The sheet is updated each Monday morning.

The Ohio State University

PURPOSE

PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in advanced or specialized practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge incorporating both into the provision of patient care that improves medication therapy. Residents who successfully complete an accredited PGY2 pharmacy residency should possess competencies that qualify them for clinical pharmacist and/or faculty positions and position them to be eligible for attainment of board certification in that practice area (when board certification for the practice area exists).

The purpose of the PGY2 Hematology/Oncology residency is to develop specialized knowledge in the pathophysiology and management of patients with hematology and oncology disorders. This is accomplished through core rotations to strengthen hematology and oncology fundamentals as well as elective rotations with the flexibility to meet the individual’s needs.

The program is designed to develop the resident’s clinical expertise and additionally provide opportunities for teaching, research, and quality improvement. Pharmacists completing the residency will be trained as clinical specialists able to excel as an independent practitioner. The goal of the program is to become an integral member of a Hematology/Oncology multidisciplinary team in a large academic setting.

RESIDENCY SITES

The Ohio State University Comprehensive Cancer Center – James Cancer Hospital is ranked nationally as one of the top hospitals for cancer care, maintaining an “exceptional” rating – the highest descriptor given by the National Cancer Institute, and is the third largest cancer center in the nation. Recently opened in December 2014, with 21 floors spanning 1.1 million square feet, the new James Cancer Hospital and Solove Research Institute revolutionizes the way cancer prevention and care are provided, with over 200 specialized oncologists and cancer researchers working side-by-side to unlock the mysteries of what causes cancer and, using those discoveries, transition from cancer treatment to cancer prevention.

This 356-bed adult cancer clinical care facility, including a 36-bed blood and marrow transplant unit, is a member of the National Comprehensive Cancer Network, the National Cancer Institute’s National Clinical Trial Network— notably one of only four centers funded by the NCI to conduct both Phase I and II clinical trials on novel anticancer drugs, achieved Magnet® designation for excellence in patient care, and is fully accredited by the Joint Commission, the American College of Surgeons Common on Cancer and the Foundation for the Accreditation of Cellular Therapy. The center includes six outpatient chemotherapy infusion clinics, dispensing an estimate of over 75,000 doses of chemotherapy annually. The Department of Pharmacy consists of inpatient and outpatient hematology/oncology clinical specialist pharmacists, pain and palliative medicine pharmacists, anti-coagulation pharmacists, cancer informatics pharmacists, medication assistance pharmacists, and Hematology/Oncology specialty practice pharmacy residents.

The James Cancer Hospital at The Ohio State University offers a one-year postgraduate year two (PGY2) ASHP accredited oncology pharmacy residency program. The clinical pharmacy program is designed to align with our subspecialized disease specific model allowing residents the opportunity to train with clinical specialists who are experts in their subspecialty in both inpatient and ambulatory clinic setting. The program allows residents to develop their hematology/oncology knowledge base including cancer treatment, supportive care, and the role of clinical trials in this patient population. Upon completion of the program, the resident will have the skillset necessary to work as a respected member of a multi-disciplinary hematology/oncology patient care team.

KEY ROTATIONS/EXPERIENCES

The resident will complete a combination of rotations and longitudinal experiences designed around the core objectives specified by ASHP in addition to the resident’s interest.

Inpatient Acute Leukemia

Bone Marrow Transplantation.

Inpatient Benign Hematology and Lymphoma/Myeloma

Inpatient Oncology

Outpatient Hematology Clinics

Benign Hematology

Lymphoma

Myeloma

BMT and Acute Leukemia

Outpatient Oncology Clinics

Breast Cancer

Gastrointestinal Cancer

Gynecologic Cancer

Lung Cancer

Genitourinary Cancer

Head & Neck/Sarcoma

NeuroOncology

Melanoma

Other Outpatient Clinics

Oncology Anticoagulation

Clinical Trials Unit

Pain and Palliative Care

Investigational Drug Service

Oncology Administration

Informatics

Teaching

Infectious Disease

Medication Safety

About The Ohio State University

As one of America’s top ranked academic medical centers, the mission of
The Ohio State University Wexner Medical Center (OSUWMC) is to
improve people’s lives through innovation in research, education, and
patient care. OSUWMC is a 1443 bed multihospital delivery system
recognized in 2018 as one of “America’s Best Hospitals” for excellence in
ten specialties by US News and World Report based on quality, outcomes,
and reputation. OSUWMC is home to more "Top Doctors" than any other
central Ohio hospital.